SARS-CoV-2 and probable lung cancer risk

被引：6

作者：

Khiali, Sajad ^{[1
]}

Rezagholizadeh, Afra ^{[1
]}

Entezari-Maleki, Taher ^{[1
,2
]}

机构：

[1] Tabriz Univ Med Sci, Dept Clin Pharm, Fac Pharm, Tabriz, Iran

[2] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran

来源：

BIOIMPACTS | 2022年 / 12卷 / 03期

关键词：

COVID-19; SARS-CoV-2; Oncovirus; Lung cancer; Lung fibrosis; INFLAMMATION;

D O I：

10.34172/bi.2022.23266

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development.

引用

页码：291 / 292

页数：2

共 50 条

[1] Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
Kong, Qi
Xiang, Zhiguang
Wu, Yue
Gu, Yu
Guo, Jianguo
Geng, Fei
MOLECULAR CANCER, 2020, 19 (01)
[2] SARS-CoV-2 Infection and Lung Cancer: Potential Therapeutic Modalities
Gupta, Ishita
Rizeq, Balsam
Elkord, Eyad
Vranic, Semir
Al Moustafa, Ala-Eddin
CANCERS, 2020, 12 (08) : 1 - 21
[3] Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
Qi Kong
Zhiguang Xiang
Yue Wu
Yu Gu
Jianguo Guo
Fei Geng
Molecular Cancer, 19
[4] SARS-CoV-2 infection as a potential risk factor for the development of cancer
Ogarek, Natalia
Oboza, Paulina
Olszanecka-Glinianowicz, Magdalena
Kocelak, Piotr
FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
[5] Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection
Chen, Long
Liu, Yue
Wu, Jiamin
Deng, Chao
Tan, Jianjun
Liu, Huawen
Zhong, Li
AGING-US, 2021, 13 (02): : 1620 - 1632
[6] Probable Vertical Transmission of SARS-CoV-2 Infection
Demirjian, Alicia
Singh, Cheentan
Tebruegge, Marc
Herbert, Rachel
Draz, Nehal
Mirfenderesky, Mariyam
Jones, Victoria
Hinstridge, Peter
Seneviratne, Ranjika
Myers, Richard
Ellis, Joanna
Miah, Shahjahan
Meadows, Christopher I. S.
Kenny, Julia
Alonso, Alejandra
Handforth, Jennifer
Perkins, Shona
Butler, Mark
Blackburn, Frances
Douthwaite, Sam
Pillay, Deenan
Chand, Meera
Zambon, Maria
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2020, 39 (09) : E257 - E260
[7] Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung Cancer
Trontzas, Ioannis P.
Vathiotis, Ioannis
Economidou, Christina
Petridou, Ioulia
Gomatou, Georgia
Grammoustianou, Maria
Tsamis, Ioannis
Syrigos, Nikolaos
Anagnostakis, Maximilian
Fyta, Eleni
Sakka, Vissaria
Poulakou, Garyphalia
Kotteas, Elias A.
Syrigou, Ekaterini
VACCINES, 2022, 10 (04)
[8] SARS-COV-2 infection and lung tumor microenvironment
Malkani, Naila
Rashid, Muhammad Usman
MOLECULAR BIOLOGY REPORTS, 2021, 48 (02) : 1925 - 1934
[9] SARS-COV-2 infection and lung tumor microenvironment
Naila Malkani
Muhammad Usman Rashid
Molecular Biology Reports, 2021, 48 : 1925 - 1934
[10] Immunoreaction to pandemic SARS-CoV-2 infection in lung tissue Immunoreaction to SARS-CoV-2 in lung tissue
Rivera, Jorge
Corchuelo, Sheryll
Parra, Edgar
Aladino, Eugenio
Mercado, Marcela
Torres-Fernandez, Orlando
BIOMEDICA, 2022, 42 (02): : 1 - 14

← 1 2 3 4 5 →